INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 103 filers reported holding INHIBRX INC in Q3 2022. The put-call ratio across all filers is 34.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,679,557 | +42.4% | 91,529 | +101.4% | 0.00% | – |
Q2 2023 | $1,179,545 | +77.6% | 45,437 | +29.1% | 0.00% | – |
Q1 2023 | $664,224 | -23.4% | 35,200 | 0.0% | 0.00% | – |
Q4 2022 | $867,328 | +37.2% | 35,200 | 0.0% | 0.00% | – |
Q3 2022 | $632,000 | -71.6% | 35,200 | -82.1% | 0.00% | -100.0% |
Q2 2022 | $2,229,000 | -2.6% | 196,402 | +91.2% | 0.00% | 0.0% |
Q1 2022 | $2,289,000 | -52.8% | 102,716 | -7.5% | 0.00% | -50.0% |
Q4 2021 | $4,849,000 | +46.1% | 111,029 | +11.5% | 0.00% | +100.0% |
Q3 2021 | $3,318,000 | +402.7% | 99,602 | +315.4% | 0.00% | – |
Q2 2021 | $660,000 | – | 23,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |